Clinical trial

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

NCT06085833

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-11-02

PhaseNA

Study timeline

Study start (actual)2023-11-02Date precision: day

Registry last updated2026-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Nanomechanical Phenotype TestDIAGNOSTIC_TEST

Sponsors & collaborators

ARTIDIS AGlead sponsor

Mapped research locations

HoustonTexas, United States2 DallasTexas, United States1 SeattleWashington, United States1 BarcelonaBarcelona, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06085833 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.